Prediction of Locoregional Control in Head and Neck Squamous Cell Carcinoma with Serial CT Perfusion during Radiotherapy

References

1. 1.↵
   American Cancer Society. Cancer Facts and Figures 2009. Atlanta, Georgia: American Cancer Society; 2009
2. 2.↵
   1. Brizel DM,
   2. Sibley GS,
   3. Prosnitz LR,
   4. et al

   . Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997;38:285–89

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Ljungkvist AS,
   2. Bussink J,
   3. Rijken PF,
   4. et al

   . Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2002;54:215–28

   PubMedWeb of Science
4. 4.↵
   1. Miles KA.

   . Perfusion CT for the assessment of tumour vascularity: which protocol? Br J Radiol 2003;76(spec no 1):S36–42

   Abstract/FREE Full Text
5. 5.↵
   1. Gandhi D,
   2. Hoeffner EG,
   3. Carlos RC,
   4. et al

   . Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract: initial results. J Comput Assist Tomogr 2003;27:687–93

   CrossRefPubMed
6. 6.↵
   1. Surlan-Popovic K,
   2. Bisdas S,
   3. Rumboldt Z,
   4. et al

   . Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy. AJNR Am J Neuroradiol 2010;31:570–75

   Abstract/FREE Full Text
7. 7.↵
   American Joint Committee on Cancer. AJCC Cancer Staging Manual, 6th ed. New York: Springer; 2002
8. 8.↵
   1. Hermans R,
   2. Meijerink M,
   3. Van den Bogaert W,
   4. et al

   . Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:1351–56

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Bisdas S,
   2. Rumboldt Z,
   3. Surlan-Popovic K,
   4. et al

   . Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements. AJNR Am J Neuroradiol 2010;31:576–81

   Abstract/FREE Full Text
10. 10.↵
    1. Bisdas S,
    2. Rumboldt Z,
    3. Wagenblast J,
    4. et al

    . Response and progression-free survival in oropharynx squamous cell carcinoma assessed by pretreatment perfusion CT: comparison with tumor volume measurements. AJNR Am J Neuroradiol 2009;30:793–99

    Abstract/FREE Full Text
11. 11.↵
    1. Hall E

    . Radiobiology for the Radiologist. Philadelphia: Lippincott Williams & Wilkins; 2000
12. 12.↵
    1. De Schutter H,
    2. Landuyt W,
    3. Verbeken E,
    4. et al

    . The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy ± chemotherapy. BMC Cancer 2005;5:42

    CrossRefPubMed
13. 13.↵
    1. Artman T,
    2. Schilling D,
    3. Gnann J,
    4. et al

    . Irradiation-induced regulation of plasminogen activator inhibitor type-1 and vascular endothelial growth factor in six human squamous cell carcinoma lines of the head and neck. Int J Radiat Oncol Biol Phys 2010;76:574–82

    CrossRefPubMed
14. 14.↵
    1. Ng QS,
    2. Goh V,
    3. Milner J,
    4. et al

    . Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: in vivo whole tumor assessment using volumetric perfusion computed tomography. Int J Radiat Oncol Biol Phys 2007;67:417–24

    PubMed
15. 15.↵
    1. Cao Y,
    2. Popovtzer A,
    3. Li D,
    4. et al

    . Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study. Int J Radiat Oncol Biol Phys 2008;72:1287–90

    PubMed
16. 16.↵
    1. Schmitt P,
    2. Kotas M,
    3. Tobermann A,
    4. et al

    . Quantitative tissue perfusion measurements in head and neck carcinoma patients before and during radiation therapy with a non-invasive MR imaging spin-labeling technique. Radiother Oncol 2003;67:27–34

    CrossRefPubMed
17. 17.↵
    1. Posner MR,
    2. Hershock DM,
    3. Blajman CR,
    4. et al

    . Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705–15

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Vermorken JB,
    2. Remenar E,
    3. van Herpen C,
    4. et al

    . Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007;357:1695–704

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Zima AJ,
    2. Wesolowski JR,
    3. Ibrahim M,
    4. et al

    . Magnetic resonance imaging of oropharyngeal cancer. Top Magn Reson Imaging 2007;18:237–42

    CrossRefPubMed
20. 20.↵
    1. Bisdas S,
    2. Nguyen SA,
    3. Anand SK,
    4. et al

    . Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys 2009;73:1313–18

    PubMed
21. 21.↵
    1. Lehtio K,
    2. Eskola O,
    3. Viljanen T,
    4. et al

    . Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;59:971–82

    CrossRefPubMed
22. 22.↵
    1. Bisdas S,
    2. Spicer K,
    3. Rumboldt Z.

    . Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging. AJNR Am J Neuroradiol 2008;29:1376–81

    Abstract/FREE Full Text
23. 23.↵
    1. Faggioni L,
    2. Neri E,
    3. Bartolozzi C.

    . CT perfusion of head and neck tumors: how we do it. AJR Am J Roentgenol 2010;194:62–69

    CrossRefPubMed
24. 24.↵
    1. Gandhi D,
    2. Chepeha DB,
    3. Miller T,
    4. et al

    . Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol 2006;27:101–06

    Abstract/FREE Full Text